3 completed, 1 unknown. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Unknown 1 |
Follow Seppic: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults Glycovax-002 - SARS-CoV-2 | Phase 1 | Unknown | Glycovax Pharma Inc. | 36 | 2023-04-28 | 2024-09-24 |
| Clinical Trial to Study the COVAC-2 Booster Dose (for COVID-19) in Generally Healthy Adults. COVAC-2, Saline Placebo - Double Vaccinated for COVID-19 (For Phase 1 of the Study), Acute Respiratory Syndrome Coronavirus 2 (For Phase 2 Exploratory Group) | Phase 1 | Completed | University of Saskatchewan | 60 | 2022-07-22 | 2024-05-03 |
| A Clinical Trial of COVAC-2 in Healthy Adults COVAC-2, Saline Placebo - Severe Acute Respiratory Syndrome Coronavirus 2 | Phase 1 | Completed | University of Saskatchewan | 61 | 2021-02-10 | 2023-05-19 |
| Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers PfAMA-1-FVO[25-545] - Plasmodium Falciparum Malaria | Phase 1 | Completed | European Vaccine Initiative | 56 | 2005-11-01 | 2008-08-08 |
COVID-19 (1) · Malaria, Falciparum (1)
Canada (2) · Australia (1) · Netherlands (1)
Joanne M Langley, MD (1) · Kristi McLendon, MD (1) · Robert Sauerwein, Prof. MD (1)